Acute lymphoblastic leukemia associated with RCSD1–ABL1 novel fusion gene has a distinct gene expression profile from BCR–ABL1 fusion

Saved in:
Bibliographic Details
Published inLeukemia Vol. 27; no. 6; pp. 1422 - 1424
Main Authors De Braekeleer, E, Douet-Guilbert, N, Guardiola, P, Rowe, D, Mustjoki, S, Zamecnikova, A, Al Bahar, S, Jaramillo, G, Berthou, C, Bown, N, Porkka, K, Ochoa, C, De Braekeleer, M
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.06.2013
Nature Publishing Group
Springer Nature
Subjects
631/1647/2217/2018
631/208/68
692/699/67/1990/283/2125
Acute lymphoblastic leukemia
Acute lymphocytic leukemia
B cells
Bone marrow
Cancer Research
Cancer therapies
Cellular signal transduction
Chemotherapy
Chromosomes, Human, Pair 1
Chromosomes, Human, Pair 9
Cloning
Critical Care Medicine
Funding
Fusion protein
Gene expression
Genetic aspects
Hematology
Humans
Intensive
Internal Medicine
Intracellular Signaling Peptides and Proteins - genetics
Intracellular Signaling Peptides and Proteins - physiology
letter-to-the-editor
Letters to the editor
Leukemia
Leukemia, B-Cell - genetics
Life Sciences
Lymphatic leukemia
Lymphoma
Male
Medical prognosis
Medicine
Medicine & Public Health
Oncogene Proteins, Fusion - chemistry
Oncology
Patients
Physiological aspects
Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics
Proto-Oncogene Proteins c-abl - genetics
Remission (Medicine)
Stem cell transplantation
Translocation, Genetic
University colleges
Ecuador
United Kingdom > UK
Kuwait
Finland
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ObjectType-Article-3
ISSN:0887-6924
1476-5551
DOI:10.1038/leu.2012.332